Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9201338Aexternal-prioritypatent/SE9201338D0/en
Priority claimed from SE9202553Aexternal-prioritypatent/SE9202553D0/en
Priority claimed from SE9203897Aexternal-prioritypatent/SE9203897D0/en
Application filed by Astra AbfiledCriticalAstra Ab
Application grantedgrantedCritical
Publication of TW332816BpublicationCriticalpatent/TW332816B/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Abstract
The present invention relates a novel class of biologically active compounds, to processes for their producton and to their use in therspy. More particularly the invention provides immunogenic conjugates useful for generating T cell immunity against tumor-associated carbohydrate structures or against catbohydrate structures expressed on infectious a agents and/or infected host cells. The immunogenic conjugate comprises (I) a peptide component capable of binding a MHC class 1 molecule; and (ii) a carbohydrate component having the immunogenic specificity of the carbohydrate structure.
TW082102770A1992-04-281993-04-13Peptide and carbohydrate
TW332816B
(en)
Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)- en-20-yn-3-one